Can heterozygous MTHFR A1298C modestly reduce enzyme activity without implying impaired methylation or elevated homocysteine?

A1298C (rs1801131) is a common MTHFR polymorphism. For a 52-year-old man with heterozygous AC status, its principal implication is a possible small reduction in enzyme activity—not a diagnosis of dysfunctional methylation or hyperhomocysteinemia.

Functional and clinical evidence

• Experimental expression data estimate A1298C enzyme activity at 68% ± 5% of wild type (about a 32% reduction), while lymphocyte-extract estimates place AC activity near 83% of the AA reference (about a 17% reduction). Thus, the typical effect is modest and context-dependent rather than a severe enzyme deficiency.
• This Glu429Ala substitution lies in the C-terminal regulatory domain and is not thermolabile under tested conditions. Its isolated functional effect is generally milder than that associated with C677T.
• A meta-analysis of six A1298C studies found no convincing association with global DNA methylation. In a study of 199 participants, A1298C was not significantly associated with folate, vitamin B12, homocysteine, global DNA methylation, or related cellular measures.

Homocysteine and mechanisms

• Isolated A1298C heterozygosity does not establish elevated plasma total homocysteine; primary-study evidence found no association of the 1298C allele with total homocysteine irrespective of folate status.
• Homocysteine is more directly shaped by reversible factors: folate deficiency and vitamin B12 deficiency impair one-carbon metabolism, while reduced GFR/renal dysfunction raises homocysteine substantially through impaired clearance.
• Combined C677T/A1298C heterozygosity may have greater biochemical consequences than isolated A1298C.

Clinical implications

• “Impaired methylation” has no single universal clinical assay; global DNA methylation, locus-specific methylation, SAM/SAH balance, and metabolic flux are not interchangeable.
• If clinically indicated, assess plasma total homocysteine directly, alongside folate, B12 (and methylmalonic acid when appropriate), renal function, medications, and relevant lifestyle or endocrine contributors.

Bottom line

• A1298C AC status may modestly lower MTHFR activity, but it is not evidence by itself of impaired methylation or elevated homocysteine.